Emily Field analyst BARCLAYS

Currently out of the existing stock ratings of Emily Field, 21 are a HOLD (30.88%), 36 are a BUY (52.94%), 11 are a SELL (16.18%).

Emily Field

Work Performance Price Targets & Ratings Chart

Analyst Emily Field, currently employed at BARCLAYS, carries an average stock price target met ratio of 51.96% that have a potential upside of 19.04% achieved within 219 days.

Emily Field’s has documented 124 price targets and ratings displayed on 18 stocks. The coverage is on Healthcare, Basic Materials, Consumer Cyclical sectors.

Most recent stock forecast was given on BIIB, Biogen.

Wall Street Analyst Emily Field

Analyst best performing recommendations are on ARGX (ARGENX NV ADR).
The best stock recommendation documented was for ARGX (ARGENX NV ADR) at 12/21/2023. The price target of $361.87 was fulfilled within 1 day with a profit of $7.74 (2.19%) receiving and performance score of 21.86.

Average potential price target upside

ARGX argenx NV ADR AZN AstraZeneca PLC ADR GLPG Galapagos NV ADR GMAB Genmab AS GSK GlaxoSmithKline PLC ADR NVO Novo Nordisk A/S NVS Novartis AG ADR UCBJY UCB SA ADR SNY Sanofi ADR GRFS Grifols SA ADR HL Hecla Mining Company IP International Paper ABBV AbbVie AMGN Amgen BIIB Biogen GILD Gilead Sciences LLY Eli Lilly and Company MRK Merck mpany

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 25-Apr-2023

$1232

$349.52 (39.61%)

$1182

Buy Since 17-Jul-2023

$1090

$207.52 (23.52%)

$1078

Buy Since 17-Jul-2023

$1120

$237.52 (26.92%)

$1185

Buy Since 18-Aug-2026

$1190

$307.52 (34.85%)

$1250

Buy Since 14-Sep-2018

$1336

$453.52 (51.39%)

$1356

Show more analysts

Please expand the browser size to see the chart

Which stock is Emily Field most bullish on?

Potential upside of $126.54 has been obtained for LLY (ELI LILLY AND COMPANY)

Which stock is Emily Field most reserved on?

Potential downside of -$39.26 has been obtained for AMGN (AMGEN)

What Year was the first public recommendation made by Emily Field?

On 2018
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?